cas 220349-80-4|| where to buy Cyclopropanamine, 2-(4-fluorophenyl)-, (1R,2S)- (9CI)

Nom du produit:Cyclopropanamine, 2-(4-fluorophenyl)-, (1R,2S)- (9CI)

IUPAC Name:(1R,2S)-2-(4-fluorophenyl)cyclopropan-1-amine

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM433351-1g	in stock	ũũũț

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 220349-80-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:220349-80-4; Formule moléculaire:C9H10FN; Point de fusion:-; Code SMILES:N[C@@H]1C[C@H]1C1=CC=C(F)C=C1; Densité:

: Numéro de catalogue:CM433351; Poids moléculaire:151.18; Point d'ébullition:; N° Mdl:MFCD17010161; Stockage:

: Bomedemstat; Merck recently announces the initiation of the pivotal Phase 3 randomized MK-3543-006 clinical trial of Bomedemstat for Essential Thrombocythemia (ET). Lysine-specific demethylase 1 (LSD1) is critical for the regulation of hematopoietic stem and progenitor cells. Bomedemstat is an investigational small molecule irreversible inhibitor of LSD1 by suppressing progenitor cells during blood cell maturation. It is generally well tolerated in ET patients and demonstrates significant clinical activity as a monotherapy.
Bomedemstat has been granted Orphan Drug and Fast Track Designation for the treatment of ET and myelofibrosis (MF) by the U.S. FDA.